Jiang-Hui (Sloan) Wang
@sloanjhwang
Research fellow, biologist in gene therapy, data scientist, and all-around nerd.
ID: 782773908
26-08-2012 16:44:30
39 Tweet
76 Followers
314 Following
Excited to see our research led by Guei-Sheung (Rick) Liu featured on the cover of Theranostics! Use nanoparticles to deliver the inhibitor of TAK1 to treat corneal neovascularization. thno.org/v12p0657.pdf Centre for Eye Research Australia
Our recent research shows the use of nanoparticle-based eye drops to improve corneal health! See the research featured on the cover of Theranostics Theranostics 2022;12(2):657-674. doi:10.7150/thno.65098 cera.org.au/high-tech-eye-…
Happy to share my PhD work out at Nucleic Acid Therapeutics, which shows miR-143 is essential for limiting endothelial cell–matrix adhesion, thus suppressing retinal neovascularization. w/Guei-Sheung (Rick) Liu Centre for Eye Research Australia paper: liebertpub.com/doi/10.1089/na…
Happy to share our pre-print work on MedRxiv. We defined the genes associated with age and AMD severity and cellular landscape of the aging retina in AMD patients with the EyeGEx database. w/Guei-Sheung (Rick) Liu Raymond Wong Centre for Eye Research Australia medrxiv.org/content/10.110…
Our latest preprint on Retinal transcriptome and cellular landscape in relation to the progression of diabetic retinopathy. Guei-Sheung (Rick) Liu Raymond Wong medrxiv.org/cgi/content/sh…
Our gene therapy work led by Dr Tom Edwards on an inherited retinal disease - Bietti crystalline dystrophy is finally out at Nature Portfolio. Thanks our collaborators @AlicePebay Dr. Grace Lidgerwood. Centre for Eye Research Australia nature.com/articles/s4159…
I am incredibly lucky to work with Tom and the Retinal Gene Therapy team at Centre for Eye Research Australia - this article by Liam Mannix The Age explains why these treatments are so important to patients and their families. #IRD #genetherapy smh.com.au/national/a-new…
Thrilled to be selected as a recipient of 2022 Australia to USA Graduate Scholarship by American Australian Association for my postdoc study at Yale. American Australian Association Centre for Eye Research Australia Yale University americanaustralian.org/2022-australia…
Happy to share our latest bioinformatic work on DR out at IOVS Journal. We for the first time identified severity-associated genes, and profiled both immune cells and retinal cells in relation to DR. Guei-Sheung (Rick) Liu Raymond Wong Centre for Eye Research Australia iovs.arvojournals.org/article.aspx?a…
Gene therapy is a promising one-off treatment for many inherited eye diseases, including Bietti crystalline dystrophy. We're working hard in the lab to deliver this hope at Centre for Eye Research Australia. Centre for Eye Research Australia cera.org.au/crystal-meltin…
Happy to share our years of work on TAK1 in retinal neovascularization, finally out at @PharmacolRes. Our data suggests TAK1 plays a crucial role in retinal neovascular pathologies and thus could be a therapeutic target. Guei-Sheung (Rick) Liu Centre for Eye Research Australia doi.org/10.1016/j.phrs…
Our transcriptomic analysis with large number of retinal samples from patients with AMD are out at IOVS. Guei-Sheung (Rick) Liu Centre for Eye Research Australia Raymond Wong
Thrilled to share our comprehensive review with AAV pioneer Dr. Guangping Gao on rAAV as a gene therapy delivery vector for human diseases. Now live on @nature Signal Transduction and Targeted Therapy! Signal Transduction and Targeted Therapy (STTT) Centre for Eye Research Australia American Australian Association nature.com/articles/s4139…
Breaking Down 2025’s AAV Gene Therapy Advances for Retinal Diseases My summary with Retina Australia explores how these innovations could transform care for IRDs and AMD. retinaaustralia.com.au/aav-based-gene… #GeneTherapy #VisionResearch
